All stock lists
Aclaris Therapeutics, Inc. (ACRS)
United States · Delayed Price · Currency is USD
Pharmaceutical Preparations
3.81+0.06 (+1.73%)
Insider Score
––Not scored
ACRS Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ACRS analyst forecast
ACRS analyst consensus
No analyst ratings in the last 3 months.
ACRS 12-month price target
$10.00+161.8% upsideaverage of 1 firm
$10.00High
$10.00Low
Best analysts covering ACRS
No firm covering ACRS has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ACRS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Canaccord Genuity | — | $10.00 | +65.3% | — | 2026-09-01 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.